Associated Papers
Large-scale targeted sequencing identifies risk genes for neurodevelopmental disorders.
Wang T et al.
Nature Communications, 2020
33004838 (PubMed )
Supplement: 41467_2020_18723_MOESM10_ESM.xlsx › Supplementary_Data_8
Rare genetic susceptibility variants assessment in autism spectrum disorder: detection rate and practical use.
Husson T et al.
Translational Psychiatry, 2020
32094338 (PubMed )
Supplement: 41398_2020_760_MOESM2_ESM.xlsx › De_novo
A De Novo Mutation in DYRK1A Causes Syndromic Intellectual Disability: A Chinese Case Report.
Qiao F et al.
Frontiers in Genetics, 2019
31803247 (PubMed )
Supplement: DataSheet_2.pdf
Clinical phenotype of ASD-associated DYRK1A haploinsufficiency.
Earl RK et al.
Molecular Autism, 2017
29034068 (PubMed )
Supplement: 13229_2017_173_MOESM1_ESM.xlsx › NM101395.2_snvs_indels
Experience of a multidisciplinary task force with exome sequencing for Mendelian disorders.
Fokstuen S et al.
Human Genomics, 2016
Disruptive de novo mutations of DYRK1A lead to a syndromic form of autism and ID.
van Bon BW et al.
Molecular Psychiatry, 2016
Select a paper to view details